Two co-founders of Fullerton Healthcare Corporation in Singapore have been ordered to pay fines totalling S$160,000 after pleading guilty to falsifying entertainment claims linked to more than S$211,000 in inflated expenses. Daniel Chan Pai Sheng and Michael Tan Kim Song, both 52-year-old physicians, faced prosecution for accounts falsification, though neither doctor benefited directly from the scheme. Instead, the illegally diverted funds were intended to assist Collin Chiew, the third party in the arrangement whose case remains pending in court.
Chan received the heavier penalty of S$135,000 following his admission of guilt to five counts of falsification of accounts. The scale of his scheme was substantial: claims totalling more than S$336,000 were submitted when actual expenses amounted to approximately S$125,000, creating an inflated discrepancy of over S$211,000. This represents a significant disparity between the amounts recorded and legitimate business expenditures. Tan's culpability was comparatively narrower, attracting a fine of S$25,000 for a single count of falsification linked to one of Chan's offences. In Tan's case, a false claim of around S$82,000 concealed actual costs of just over S$42,000, resulting in an overstated sum of nearly S$40,000 that formed part of the larger fraudulent total.
Chiew, aged 58, held a senior executive position as chief executive of insurance broker Aon Singapore between January 2015 and July 2018. Court documents indicate his request for financial assistance provided the catalyst for the scheme, though records do not clarify whether he ultimately received the misappropriated funds. The arrangement emerged around 2015 when Chiew approached Chan requesting money to address pressing personal financial obligations related to his children's welfare and residential mortgage. Chan subsequently involved Tan in discussions about fulfilling this request, setting in motion the coordinated falsification strategy.
The mechanics of the fraud operated through a sophisticated Hong Kong-centred arrangement. Chan made approximately twice-monthly business trips to the territory, ostensibly to support Fullerton Healthcare Corporation's operations. Before departing Singapore, he would instruct David Sin, the third co-founder, to obtain inflated or fabricated Karaoke and entertainment venue receipts. A man named Tei Chu Pink, 46, served as the document supplier, generating receipts inflated to cover the intended financial assistance to Chiew. During Hong Kong visits, Chan would socialise with Sin and Tei at KTV establishments while ostensibly meeting potential investors, then collect the doctored receipts. On certain occasions, Chan would make minimal actual payments using personal funds or credit cards; on others, no genuine payment occurred at all.
Upon returning to Singapore, Chan ensured these fabricated receipts reached appropriate individuals within Fullerton Healthcare Corporation's administrative structure and its subsidiary Fullerton Health China. These personnel subsequently processed the claims through official channels, converting the false entertainment expenses into legitimate reimbursement requests. Critically, multiple instances operated with Tan's explicit knowledge and tacit cooperation, transforming individual misconduct into a coordinated corporate fraud. In 2016, all three men conspired together to fabricate a single entertainment claim, demonstrating the systematic and deliberate nature of the deception rather than isolated lapses in judgment.
The broader business context reveals that Tan and Chan established Fullerton Healthcare Group in 2010, building a healthcare enterprise providing medical services through a network of practitioners and specialists while facilitating client insurance claim processing. Around 2012, seeking to expand business opportunities and investor connections, the pair met Chiew through professional networks. The introduction proved consequential: when Chiew's financial difficulties materialised three years later, the relationship positioned him to leverage his connections to the founders for assistance, ultimately compromising their integrity and legal standing.
During the investigation and prosecution process, the Corrupt Practices Investigation Bureau disclosed that Tan held directorships at Fullerton Healthcare Group, while Chan served as president of Fullerton Health China, with both entities operating as subsidiaries of the parent Fullerton Healthcare Corporation. Both men have since relinquished these positions, effectively removing them from operational control of the entities implicated in the scandal. This structural detail underscores how the fraud exploited their executive authority to manipulate financial systems and documentation within their own organisations.
Interestingly, graft-related charges were initially filed against both defendants, reflecting investigative suspicions of corruption rather than straightforward fraud. However, prosecutors exercised discretionary authority to seek discharge not amounting to acquittal on all corruption-related counts, a procedural mechanism that preserves the possibility of future prosecution should new evidence emerge. This prosecutorial decision suggests possible complexities in establishing corruption elements, or alternatively, a judgment that falsification charges adequately addressed the misconduct. District Judge Paul Quan approved the discharge application on July 10.
The timeline of guilty pleas occurred rapidly, with both doctors admitting culpability on July 8, followed by sentencing two days later. This expedited process indicates limited defence contestation and relatively straightforward factual evidence. Notably, a third co-founder, David Sin, had previously entered guilty pleas in August 2025 to six falsification counts and received an identical S$160,000 fine to Chan's penalty, suggesting coordinated judicial calibration of sentences based on involvement severity.
For Malaysian readers and Southeast Asian businesses, this case illustrates critical vulnerabilities in corporate governance and documentation controls, particularly within professional services and healthcare sectors where individuals with specialist credentials wield significant administrative authority. The sophistication of the scheme—operating across multiple jurisdictions, involving multiple participants, and persisting over several years—demonstrates that fraud can flourish when internal approval mechanisms lack adequate oversight and segregation of duties. The case emphasises that professional credentials and founding status provide no inoculation against legal liability when individuals knowingly participate in falsifying financial records. For companies operating regionally, the penalties, reputational damage, and removal of key personnel from operational roles represent substantial consequences that extend well beyond financial fines.
